Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04074044 · ClinicalTrials.gov registry record · NA
Evaluation of a New Bladder Health Mobile Application in Pregnancy
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04074044 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 50 participants.
The verdict
NCT04074044, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Millions of women experience involuntary loss of urine called urinary incontinence (UI). UI can be slightly bothersome or totally debilitating. Women experience UI twice as often as men. Urinary incontinence can also be a persistent condition caused by underlying physical problems or changes, including pregnancy and childbirth. UI symptom severity progress dynamically and are also sustained over time. High quality evidence shows that pelvic floor muscle training (PFMT) during pregnancy effectively reduces the risk of UI during pregnancy and the postpartum period. There is a critical need for a low cost and easily accessible program to prevent UI in pregnancy and postpartum that can reach a large number of women. A mobile health application that teaches UI preventive program during pregnancy has the potential of being a cost effective tool to reach a large number of pregnant women. The Bladder Health Mobile Application (BHmApp) will teach pregnant women new habits and exercises that will keep their bladder healthy during pregnancy and decrease the risk of UI during this period of a woman's life that is considered high risk for developing UI. In this pilot study, it is proposed to evaluate the understand and effectively use the BHmApp, and the feasibility of using the BHmApp during pregnancy.
Interventions
- BEHAVIORAL BHmApp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-04-20 |
| Est. Completion | 2024-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04074044
The ClinicalTrials.gov registry entry for NCT04074044 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BHmApp is the first listed.
NCT04074044 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04074044 about?
NCT04074044 is a clinical study titled "Evaluation of a New Bladder Health Mobile Application in Pregnancy". Millions of women experience involuntary loss of urine called urinary incontinence (UI). UI can be slightly bothersome or totally debilitating. Women experience UI twice as often as men. Urinary incontinence can also be a persistent condition caused by underlying physical problems or changes, includ...
What is the current status of trial NCT04074044?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-04-20. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT04074044?
The interventions under investigation include: BHmApp (BEHAVIORAL).
Who is sponsoring clinical trial NCT04074044?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.